| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 6 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | Canada | 2 | |
| #4 | United States | 2 | |
| #5 | Japan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Micro-structure and nano-technology | |
| #3 | Medical technology | |
| #4 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Nanostructure applications | |
| #4 | Specific use of cosmetics | |
| #5 | Syringes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Al-Ghananeem Abeer M | 13 |
| #2 | Digenis George A | 4 |
| #3 | Deluca Patrick | 4 |
| #4 | Malkawi Ahmad | 4 |
| #5 | Moyer Elizabeth | 1 |
| #6 | Malkawi Ahamad | 1 |
| #7 | Al-Ghananem Abeer M | 1 |
| #8 | Hirtzer Pamela | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2015157212A1 | Stable apomorphine composition and uses thereof | |
| EP2328530A2 | Transdermal delivery of apomorphine using microneedles | |
| WO2009158477A1 | Skin patches and sustained-release formulations comprising lofexidine for transdermal and oral delivery | |
| WO2009120735A1 | Composition and method for transmucosal delivery of lofexidine | |
| EP2583670A1 | Co-solvent compositions and methods for improved delivery of dantrolene therapeutic agents |